Dana-Farber Researchers Find Less Treatment May be More in Mantle Cell Lymphoma 

For a long time, the standard treatment for younger patients with newly diagnosed mantle cell lymphoma involved intensive chemotherapy, called induction therapy, followed by autologous stem cell transplant (ASCT, where the patient’s own stem cells are used), followed by maintenance therapy to help keep the cancer from coming back.   Based on recent clinical research involving … Read more

Follicular Lymphoma Patient Has Time On His Side After CAR T-Cell Therapy 

After nearly nine years of living with follicular lymphoma, a type of non-Hodgkin lymphoma (NHL), it took just a few minutes for things to change dramatically for Marc Cummings this spring.   That was all the time needed to transfer the small bag of modified CAR T-cells — which had been recrafted from Cummings’ own T … Read more

First CAR T-Cell Therapy for Mantle Cell Lymphoma will ‘Change Landscape’

Two years ago, with a new wife and large extended family on his mind, Jose Dos Anjos told caregivers he would do anything to help himself and others facing the aggressive, life-threatening blood cancer known as mantle cell lymphoma (MCL). Now, thanks in part to this willingness, he and fellow MCL patients have renewed hope … Read more

What Are Precursor Blood Conditions and How Are They Treated?

Precursor conditions are early phases of diseases that may develop into cancers such as lymphoma, leukemia, Waldenström’s macroglobulinemia, and multiple myeloma. Most people with precursor conditions do not experience symptoms, and since doctors rarely screen for these conditions, they are sometimes found through routine blood tests but often remain undiagnosed.  “Many diagnoses are purely incidental,” says Irene Ghobrial, MD, director … Read more